Source: Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pieter S. Hiemstra, Anne M. van der Does. Reprogramming of cellular metabolism: driver for airway remodelling in COPD?. Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017

Member's Comments

No comment yet.

Related content which might interest you: The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 The role of altered stem cell function in airway and alveolar repair and remodelling in COPD Source: Eur Respir Monogr 2021; 91: 322-339 Year: 2021 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Altered airway epithelial cell specification in COPD Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling? Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017 Year: 2017 Are asthma and COPD translation control diseases? Translational defect of cell cycle regulators C/EBP-α and -δ in airway smooth muscle cells (ASMC) of patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 20s Year: 2005 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Inflammatory cells and airway remodelling in COPD Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Defective metabolic adaptation in the pathogenesis of COPD Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Investigating mitochondrial dysfunction in asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 MicroRNA-34a drives small airway fibroblast cellular senescence in COPD Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 Essential roles of q110 in IL13 in airway remodelling in bronchial asthma Source: Annual Congress 2009 - Airways remodelling Year: 2009 Reduced MicroRNA-19a causes constitutive high expression of PRMT1 and remodeling in asthma Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016